本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ANI Pharmaceuticals, Inc.

75.39
+1.802.45%
盤後75.390.00000.00%16:46 EDT
成交量:58.60萬
成交額:4,400.86萬
市值:17.32億
市盈率:16.61
高:75.67
開:73.68
低:73.54
收:73.59
52周最高:98.55
52周最低:69.58
股本:2,297.04萬
流通股本:2,028.20萬
量比:1.58
換手率:2.89%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
淨資產收益率:20.46%
總資產收益率:5.45%
市淨率:2.90
市盈率(LYR):22.71

資料載入中...

2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/05

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

重要事件披露

Form 8-K - Current report
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/10/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/02

重要事件披露

Form 8-K - Current report
2023/09/25

重要事件披露

Form 8-K - Current report
2023/09/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/12

重要事件披露

Form 8-K - Current report